New Enterprise Associates 16, L.P.

Insider Reports History

Location
1954 Greenspring Drive, Suite 600, Timonium, MD
Signature
/s/ Zachary Bambach, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by New Enterprise Associates 16, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mirum Pharmaceuticals, Inc. 10%+ Owner Common Stock 2.19M $61.3M $28.04 Jun 13, 2023 Direct
Trevi Therapeutics, Inc. 10%+ Owner Common Stock 10.4M $21.1M $2.02 Apr 11, 2022 Direct
Marker Therapeutics, Inc. 10%+ Owner Common Stock 1.63M $5.2M $3.20 Dec 23, 2024 Direct
Metacrine, Inc. 10%+ Owner Common Stock 2.56M $1.2M $0.47 Dec 22, 2021 Direct
NeueHealth, Inc. Director, 10%+ Owner Common Stock 0 $0 $6.84 Oct 2, 2025 Direct
Trevi Therapeutics, Inc. 10%+ Owner 3.5-Year Common Stock Warrant 1.85M Oct 18, 2021 Direct
Trevi Therapeutics, Inc. 10%+ Owner 7-Year Common Stock Warrant 1.85M Oct 18, 2021 Direct
Akouos, Inc. 10%+ Owner Common Stock 0 $12.50 Nov 30, 2022 Direct
GENOCEA BIOSCIENCES, INC. 10%+ Owner Common Stock 0 $1.25 May 25, 2022 Direct
NeueHealth, Inc. Director, 10%+ Owner Warrant (Right to Buy) 0 Oct 2, 2025 Direct

Insider Reports Filed by New Enterprise Associates 16, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NEUE NeueHealth, Inc. Oct 2, 2025 8 $5.25 4 Oct 6, 2025 Director, 10%+ Owner
MRKR Marker Therapeutics, Inc. Dec 23, 2024 1 $1.77M 4 Dec 23, 2024 10%+ Owner
NEUE NeueHealth, Inc. Oct 1, 2024 1 $0 4 Oct 3, 2024 10%+ Owner
NEUE NeueHealth, Inc. Apr 8, 2024 1 $0 4 Apr 10, 2024 10%+ Owner
MIRM Mirum Pharmaceuticals, Inc. Jun 13, 2023 1 $0 4 Jun 15, 2023 10%+ Owner
AKUS Akouos, Inc. Nov 30, 2022 1 $0 4 Dec 2, 2022 10%+ Owner
GNCA GENOCEA BIOSCIENCES, INC. May 24, 2022 2 -$751K 4 May 26, 2022 10%+ Owner
TRVI Trevi Therapeutics, Inc. Apr 11, 2022 1 $5M 4 Apr 13, 2022 10%+ Owner
MTCR Metacrine, Inc. Dec 10, 2021 3 -$494K 4 Dec 27, 2021 10%+ Owner
TRVI Trevi Therapeutics, Inc. Oct 18, 2021 3 $0 4 Oct 19, 2021 10%+ Owner